Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  non-Hodgkin lymphoma
Stage/Subtype:  non-Hodgkin lymphoma
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-7 of 7 for your search:
Start Over
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 65
Trial IDs: BP-HM-001, NCI-2013-00518, NCT01744223
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 3 months to 21 years
Trial IDs: BP-004, NCI-2015-01890, NCT02065869
A Phase 1/2, Dose Escalation, Cohort Expansion Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ASN002-101, NCI-2015-01866, NCT02440685
Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC138E, NCI-2014-02373, RV-CL-CLL-PI-003938, NCT02309515
Ibrutinib and Vaccine Therapies in Treating Patients with Asymptomatic, High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU-15012, NCI-2015-00932, 2015C0098, NCT02518555
Vaccine Therapy in Treating Patients with Previously Treated Follicular Lymphoma
Status: Temporarily closed
Phase: Phase I
Type: Treatment
Age: 40 and over
Trial IDs: 06-275, NCI-2010-00094, NCT00487305
Vaccine Therapy in Treating Patients with Lymphoplasmacytic Lymphoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2009-0465, NCI-2012-01897, NCI-2010-02091, NCT01209871
Start Over